HRTX
Heron Therapeutics Inc
Price:  
2.56 
USD
Volume:  
1,655,017.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRTX WACC - Weighted Average Cost of Capital

The WACC of Heron Therapeutics Inc (HRTX) is 8.0%.

The Cost of Equity of Heron Therapeutics Inc (HRTX) is 9.40%.
The Cost of Debt of Heron Therapeutics Inc (HRTX) is 5.85%.

Range Selected
Cost of equity 7.40% - 11.40% 9.40%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.70% - 7.00% 5.85%
WACC 6.3% - 9.6% 8.0%
WACC

HRTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.76 1.16
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 11.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.38 0.38
Cost of debt 4.70% 7.00%
After-tax WACC 6.3% 9.6%
Selected WACC 8.0%